Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
770.00 | -48,73% | -27,69% | 693.312,15 | 0,67% | 2,63% |
|
NYSE:JNJ
Johnson & Johnson
|
154.64 | 0% | 0% | 372.168,87 | 3,21% | 2,71% |
|
NYSE:MRK
Merck
|
131.19 | -10,02% | 3,18% | 332.278,86 | 2,35% | -19,03% |
|
NYSE:ABBV
AbbVie
|
166.42 | -23,06% | -12,89% | 293.875,72 | 3,77% | 7,03% |
|
NYSE:TMO
Thermo Fisher Scientific
|
595.30 | -17,43% | -8,17% | 227.235,73 | 0,26% | 14,15% |
|
SWX:NOVN
Novartis
|
93.37 | 8,15% | 21,52% | 190.512,74 | 3,56% | 4,67% |
|
NasdaqGS:AMGN
Amgen
|
312.47 | -12,26% | -3,47% | 167.619,75 | 2,86% | 5,31% |
|
ENXTPA:SAN
Sanofi
|
89.17 | 19,33% | 38,3% | 111.472,92 | 4,17% | 8,19% |
|
ASX:CSL
CSL
|
280.00 | 22,59% | 43,54% | 135.310,76 | 1,23% | 7,18% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.03 | 61,74% | 72,08% | 89.253,22 | 5,44% | 13,54% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
67.72 | 20,9% | 30,15% | 84.363,86 | 4,54% | 0,15% |
|
NYSE:SHW
Sherwin Williams
|
312.40 | 3,68% | 16,54% | 79.239,24 | 0,91% | 10,86% |
|
SWX:LONN
Lonza Group
|
529.20 | -28,51% | -13,47% | 38.164,1 | 0,76% | 0,68% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4130.00 | 0% | 0% | 6.479.696,8 | 4,74% | 0% |
|
NYSE:PPG
PPG Industries
|
134.44 | 33,89% | 49,31% | 31.641,95 | 1,93% | 5,32% |
|
NYSE:TEVA
Teva Pharmaceutical Industries
|
16.29 | -46,21% | -42,74% | 18.450,72 | 0% | -2,6% |
|
TSE:4523
Eisai
|
6779.00 | 0% | 0% | 1.968.631,52 | 2,33% | 0% |
|
NasdaqGS:INCY
Incyte
|
57.10 | 104,81% | 153,29% | 12.012,93 | 0% | 27,62% |
|
LSE:CRDA
Croda International Plc
|
47.08 | 3,58% | 22,06% | 6.807,48 | 2,29% | -2,95% |
|
XTRA:WCH
Wacker Chemie
|
103.15 | 24,07% | 74,16% | 5.000,09 | 2,84% | 4,97% |
